Industry-Led Access-To-Medicines Initiatives In Low- And Middle-Income Countries: Strategies And Evidence

Peter C. Rockers, Veronika J. Wirtz, Chukwuemeka A. Umeh, Preethi M. Swamy, and Richard O. Laing

Health Affairs. 2017 Apr; 36(4):706-713.

Systematic Differences between Cochrane and Non-Cochrane Meta-Analyses on the Same Topic: A Matched Pair Analysis

Johanna Useem, Alana Brennan, Michael LaValley, Michelle Vickery, Omid Ameli, Nichole Reinen, Christopher J. Gill

. 2017 Jan;.

Treatment Outcomes and Costs of Providing Antiretroviral Therapy at a Primary Health Clinic versus a Hospital-Based HIV Clinic in South Africa.

Lawrence C. Long , Sydney B. Rosen, Alana Brennan, Faith Moyo, Celeste Sauls, Denise Evans, Shookdev L. Modi, Ian Sanne, Matthew P. Fox

PLOS. 2016 Dec; 11(12).

Changes in second-line regimen durability and continuity of care in relation to national ART guideline changes in South Africa.

Onoya, Brennan A, Berhanu R, van der Berg, Buthelezi, Fox M.

J Int AIDS Soc.. 2016 Dec; 19(1):1-13.

Study protocol for a cluster-randomised controlled trial of an NCD access to medicines initiative: evaluation of Novartis Access in Kenya.

Peter C Rockers, Veronika J Wirtz, Taryn Vian, Monica A Onyango, Paul G Ashigbie, Richard Laing

BMJ. 2016 Nov; 6(11).

Study protocol for a cluster-randomized controlled trial of an NCD access to medicines initative: Evaluation of Novartis Access in Kenya

Rockers PC, Wirtz VJ, Vian T, Onyango MA, Ashigbie PG, Laing R.

Pharmaceutical Innovation, Access & Use. 2016 Nov; 6(11):1-7.

Essential medicines for universal health coverage

Veronika J Wirtz, Hans V Hogerzeil, Andrew L Gray, Maryam Bigdeli, Cornelis P de Joncheere, Margaret A Ewen, Martha Gyansa-Lutterodt, Sun Jing, Vera L Luiza, Regina M Mbindyo, Helene Möller, Corrina Moucheraud, Bernard Pécoul, Lembit Rägo, Arash Rashidian, Dennis Ross-Degnan, Peter N Stephens, Yot Teerawattananon, Ellen F M ‘t Hoen, Anita K Wagner, Prashant Yadav, Michael R Reich

The Lancet. 2016 Nov;.

WHO Report on Medicines Transparency Alliance (MeTA): Pathways to Transparency, Accountability and Access

Taryn Vian, Jillian C. Kohler

Geneva, Switzerland: World Health Organization; 2016 Jul.

Is Patent “Evergreening” Restricting Access to Medicine/Device Combination Products?

Reed F. Beall; Jason W. Nickerson; Warren A. Kaplan; Amir Attaran

PLOS ONE. 2016 Feb;.

Effect of zinc supplementation on serum zinc concentration and T cell proliferation in nursing home elderly: a randomized double-blind placebo-controlled trial

Junaidah B. Barnett, PhD, Maria C. Dao, PhD, Davidson H. Hamer, MD, Ruth Kandel, MD, Gary Brandeis, MD, Dayong Wu, MD, PhD, Gerard E. Dallal, PhD, Paul F. Jacques, PhD, Robert Schreiber, MD, Eunhee Kong, and Simin Nikbin Meydani, DVM, PhD

The American Journal of Clinical Nutrition. 2016 Jan;.

Evaluating availability and price of essential medicines in Boston area (Massachusetts, USA) using WHO/HAI methodology

Abhishek Sharma, Lindsey Rorden, Margaret Ewen, and Richard Laing

Journal of Pharmaceutical Policy and Practice. 2016 Jan; 9(12).

Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries

Prof Marc Mendelson, MD, Prof John-Arne Røttingen, MD, Unni Gopinathan, MD, Prof Davidson H Hamer, MD, Heiman Wertheim, MD, Buddha Basnyat, MD, Prof Christopher Butler, FRCGP, Prof Göran Tomson, MD, Manica Balasegaram, MD

The Lancet. 2015 Nov;.

Evaluating the quality and use of economic data in decisions about essential medicines

Corrina Moucheraud, Veronika J Wirtz & Michael R Reich

Bulletin of the WHO. 2015 Aug; 93:693-699.